These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12580871)

  • 21. Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer.
    Sealy R; Cridland S; Barry L; Norris R
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1343-6. PubMed ID: 3531113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
    Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
    Van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined chemotherapy and radiation for unresectable head and neck cancer.
    Taylor SG
    Cancer Treat Res; 1990; 52():195-208. PubMed ID: 1976366
    [No Abstract]   [Full Text] [Related]  

  • 25. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
    Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
    J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
    Marcial VA; Pajak TF; Kramer S; Davis LW; Stetz J; Laramore GE; Jacobs JR; Al-Sarraf M; Brady LW
    Semin Oncol; 1988 Feb; 15(1):39-60. PubMed ID: 3278390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined radiation and chemotherapy in head and neck cancer.
    Sannazzari GL; Orecchia R
    Rays; 1993; 18(3):340-54. PubMed ID: 8284450
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
    Natale D; Orlando D
    Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
    [No Abstract]   [Full Text] [Related]  

  • 31. Cetuximab plus radiotherapy for head and neck cancer.
    Armstrong JG
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710907
    [No Abstract]   [Full Text] [Related]  

  • 32. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
    Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
    Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cetuximab plus radiotherapy for head and neck cancer.
    Cengiz M; Yildiz F; Genc M
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710908
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant chemotherapy.
    Bingham HG
    Surg Clin North Am; 1986 Feb; 66(1):183-8. PubMed ID: 2418517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
    Yom SS; Rosenthal DI
    Nat Clin Pract Oncol; 2004 Nov; 1(1):14-5. PubMed ID: 16264790
    [No Abstract]   [Full Text] [Related]  

  • 36. Another look at induction chemotherapy for organ preservation in patients with head and neck cancer.
    Forastiere AA
    J Natl Cancer Inst; 1996 Jul; 88(13):855-6. PubMed ID: 8656431
    [No Abstract]   [Full Text] [Related]  

  • 37. Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas.
    Eschwège F; Sancho-Garnier H; Chassagne D; Brisgand D; Guerra M; Malaise EP; Bey P; Busutti L; Cionini L; N'Guyen T; Romanini A; Chavaudra J; Hill C
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):275-81. PubMed ID: 9308928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
    Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
    Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
    Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors.
    Van den Bogaert W; van der Schueren E; Horiot JC; De Vilhena M; Schraub S; Svoboda V; Arcangeli G; de Pauw M; van Glabbeke M
    Radiother Oncol; 1995 May; 35(2):100-6. PubMed ID: 7569017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.